丝裂原活化蛋白激酶激酶2抗体

Quantity size:

0.2ml

Concentration:

1mg/ml  丝裂原活化蛋白激酶激酶2抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.

Background:

The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP丝裂原活化蛋白激酶激酶2抗体 kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, mental retardation, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. [provided by RefSeq, Jul 2008].

丝裂原活化蛋白激酶激酶2抗体Also known as:

Cardiofaciocutaneous syndrome; CFC syndrome; Dual specificity mitogen activated protein kinase kinase 2; Dual specificity mitogen-activated protein kinase kinase 2; ERK activator kinase 2; FLJ26075; MAP kinase kinase 2; MAP2K 2; map2k2; MAPK / ERK kinase 2; MAPK/ERK kinase 2; MAPKK 2; MAPKK2; MEK 2; MEK2; Microtubule Associated Protein Kinase Kinase 2; Mitogen activated protein kinase kinase 2; Mitogen activated protein丝裂原活化蛋白激酶激酶2抗体 kinase kinase 2 p45; MKK 2; MKK2; MP2K2_HUMAN; OTTHUMP00000165826; OTTHUMP00000165827; PRKMK 2; PRKMK2 V.

Specificity:

●

Rabbit Polyclonal IgG, affinity purified by Protein A.

●

Reacts with: Human, Mouse, Rat, Chicken, .

●

Immunogen: KLH conjugated synthetic peptide derived from human MAPKK2.

●

Predicted Molecular Weight: 46kDa.

丝裂原活化蛋白激酶激酶2抗体Storage:

Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).

Application:

WB=1:100-500  ELISA=1:500-1000  IHC-P=1:100-500  IHC-F=1:100-500  Flow-Cyt=1:10-200  IF=1:100-500   
Not yet tested in other applications. 
Optimal working dilutions must be determined by the end user.

kl172Ra01血小板因子4(PF4)多克隆抗体Polyclonal Antibody to Platelet Factor 4 (PF4)

kl172Rb51血小板因子4(PF4)多克隆抗体Polyclonal Antibody to Platelet Factor 4 (PF4)

kl174Hu01髓鞘型脂肪酸结合蛋白(FABP8)多克隆抗体Polyclonal Antibody to Fatty Acid Binding Protein 8, Myelin (FABP8)

kl175Hu01干扰素α4(IFNα4)多克隆抗体Polyclonal Antibody to Interferon Alpha 4 (IFNa4)

kl177Hu01酸性葡糖苷酶α(GαA)多克隆抗体Polyclonal Antibody to Glucosidase Alpha, Acid (GaA)

kl179Hu01干扰素α2(IFNα2)多克隆抗体Polyclonal Antibody to Interferon Alpha 2 (IFNa2)

kl181Ca01中性粒细胞弹性蛋白酶(ELA2)多克隆抗体Polyclonal Antibody to Elastase 2, Neutrophil (ELA2)

kl181Hu01中性粒细胞弹性蛋白酶(ELA2)多克隆抗体Polyclonal Antibody to Elastase 2, Neutrophil (ELA2)

kl181Mu01中性粒细胞弹性蛋白酶(ELA2)多克隆抗体Polyclonal Antibody to Elastase 2, Neutrophil (ELA2)

kl181Ra01中性粒细胞弹性蛋白酶(ELA2)多克隆抗体Polyclonal Antibody to Elastase 2, Neutrophil (ELA2)

kl183Hu01半乳糖苷酶α(GLα)多克隆抗体Polyclonal Antibody to Galactosidase Alpha (GLa)

kl183Mu01半乳糖苷酶α(GLα)多克隆抗体Polyclonal Antibody to Galactosidase Alpha (GLa)

kl184Hu01层粘连蛋白β1(LAMβ1)多克隆抗体Polyclonal Antibody to Laminin Beta 1 (LAMb1)

kl190Hu01糖化血红蛋白A1c(HbA1c)多克隆抗体Polyclonal Antibody to Glycated Hemoglobin A1c (HbA1c)

kl193Bo01纤维蛋白原(FG)多克隆抗体Polyclonal Antibody to Fibrinogen (FG)

kl193Hu01纤维蛋白原(FG)多克隆抗体Polyclonal Antibody to Fibrinogen (FG)

kl193Po01纤维蛋白原(FG)多克隆抗体Polyclonal Antibody to Fibrinogen (FG)

kl193Ra01纤维蛋白原(FG)多克隆抗体Polyclonal Antibody to Fibrinogen (FG)

kl195Hu01氨基己糖苷酶Aα(HEXα)多克隆抗体Polyclonal Antibody to Hexosaminidase A Alpha (HEXa)

kl196Bo01半乳糖苷酶β(GLβ)多克隆抗体Polyclonal Antibody to Galactosidase Beta (GLb)

kl196Ca01半乳糖苷酶β(GLβ)多克隆抗体Polyclonal Antibody to Galactosidase Beta (GLb)

kl196Fi01半乳糖苷酶β(GLβ)多克隆抗体Polyclonal Antibody to Galactosidase Beta (GLb)

kl196Hu01半乳糖苷酶β(GLβ)多克隆抗体Polyclonal Antibody to Galactosidase Beta (GLb)